Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 540

1.

Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.

Morishima S, Nakamura S, Yamamoto K, Miyauchi H, Kagami Y, Kinoshita T, Onoda H, Yatabe Y, Ito M, Miyamura K, Nagai H, Moritani S, Sugiura I, Tsushita K, Mihara H, Ohbayashi K, Iba S, Emi N, Okamoto M, Iwata S, Kimura H, Kuzushima K, Morishima Y.

Leuk Lymphoma. 2015 Apr;56(4):1072-8. doi: 10.3109/10428194.2014.938326. Epub 2014 Aug 13.

PMID:
24975317
2.

Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.

Cárdenas D, Vélez G, Orfao A, Herrera MV, Solano J, Olaya M, Uribe AM, Saavedra C, Duarte M, Rodríguez M, López M, Fiorentino S, Quijano S.

Clin Exp Immunol. 2015 Nov;182(2):173-83. doi: 10.1111/cei.12682. Epub 2015 Sep 11.

3.

PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro.

Quan L, Chen X, Liu A, Zhang Y, Guo X, Yan S, Liu Y.

PLoS One. 2015 Sep 11;10(9):e0136476. doi: 10.1371/journal.pone.0136476. eCollection 2015.

4.

Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.

Pender MP, Csurhes PA, Lenarczyk A, Pfluger CM, Burrows SR.

J Neurol Neurosurg Psychiatry. 2009 May;80(5):498-505. doi: 10.1136/jnnp.2008.161018. Epub 2008 Nov 17.

5.

T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.

Nowakowska J, Stuehler C, Egli A, Battegay M, Rauser G, Bantug GR, Brander C, Hess C, Khanna N.

Cytotherapy. 2015 Sep;17(9):1280-91. doi: 10.1016/j.jcyt.2015.06.003.

PMID:
26276009
6.

Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.

Cohen M, De Matteo E, Narbaitz M, Carreño FA, Preciado MV, Chabay PA.

Int J Cancer. 2013 Apr 1;132(7):1572-80. doi: 10.1002/ijc.27845. Epub 2012 Oct 17.

7.
8.

Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection.

Legoff J, Amiel C, Calisonni O, Fromentin D, Rajoely B, Abuaf N, Tartour E, Rozenbaum W, Bélec L, Nicolas JC.

J Clin Immunol. 2004 Mar;24(2):125-34.

PMID:
15024179
9.

Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.

Ozsan N, Cagirgan S, Saydam G, Gunes A, Hekimgil M.

Pathol Res Pract. 2013 Aug;209(8):471-8. doi: 10.1016/j.prp.2013.04.014. Epub 2013 May 9.

PMID:
23726928
10.

Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.

Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, Pamer EG, Howe JG, Craft J.

J Immunol. 2004 Jan 15;172(2):1287-94.

11.

Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.

Petrara MR, Cattelan AM, Zanchetta M, Sasset L, Freguja R, Gianesin K, Cecchetto MG, Carmona F, De Rossi A.

J Clin Virol. 2012 Mar;53(3):195-200. doi: 10.1016/j.jcv.2011.12.013. Epub 2011 Dec 30.

PMID:
22209290
12.

Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.

Klatt T, Ouyang Q, Flad T, Koetter I, Bühring HJ, Kalbacher H, Pawelec G, Müller CA.

J Rheumatol. 2005 Feb;32(2):239-51.

PMID:
15693083
13.

Detection of Epstein-Barr virus-specific memory CD4+ T cells using a peptide-based cultured enzyme-linked immunospot assay.

Calarota SA, Chiesa A, Zelini P, Comolli G, Minoli L, Baldanti F.

Immunology. 2013 Aug;139(4):533-44. doi: 10.1111/imm.12106.

15.

CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.

Nikiforow S, Bottomly K, Miller G.

J Virol. 2001 Apr;75(8):3740-52.

16.

Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.

Vogl BA, Fagin U, Nerbas L, Schlenke P, Lamprecht P, Jabs WJ.

J Med Virol. 2012 Jan;84(1):119-31. doi: 10.1002/jmv.22258.

PMID:
22095540
17.

Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma.

Okamoto A, Yanada M, Miura H, Inaguma Y, Tokuda M, Morishima S, Kanie T, Yamamoto Y, Mizuta S, Akatsuka Y, Yoshikawa T, Mizoguchi Y, Nakamura S, Okamoto M, Emi N.

Cancer Sci. 2015 Nov;106(11):1576-81. doi: 10.1111/cas.12812. Epub 2015 Oct 7.

18.

Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.

Stuhlmann-Laeisz C, Szczepanowski M, Borchert A, Brüggemann M, Klapper W.

Virchows Arch. 2015 Jan;466(1):85-92. doi: 10.1007/s00428-014-1661-z. Epub 2014 Oct 23.

PMID:
25339301
19.

The Role of EBV in the Pathogenesis of Diffuse Large B Cell Lymphoma.

Healy JA, Dave SS.

Curr Top Microbiol Immunol. 2015;390(Pt 1):315-37. doi: 10.1007/978-3-319-22822-8_13. Review.

PMID:
26424652
20.

Supplemental Content

Support Center